Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
NCI Participation in PAR-18-694, Interdisciplinary Research Teams to Investigate Reciprocal Basic Behavioral and Social Linkages Between Sleep and Stress (R24 - Clinical Trial Optional) NOT-CA-18-066 NCI N/A NCI Participation PAR-18-694, Interdisciplinary Research Teams Investigate Reciprocal Basic Behavioral Social Linkages Between Sleep Stress R24 - Clinical Trial Optional) Notice Number: NOT-CA-18-… More
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) PAR-22-199 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will solicit R01 research projects that seek to investigate actionable synthetic vulnerabilities that can be… More
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) PAR-21-111 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
Notice of Correction to RFA-CA-22-022, "Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)" NOT-CA-22-090 NCI N/A The purpose of this Notice is to correct the section on Key Dates in RFA-CA-22-022, Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional… More
Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) RFA-CA-22-012 NCI This funding opportunity announcement (FOA) requests applications for PDX (patient-derived xenografts) Development and Trial Centers (PDTCs) to serve as the laboratory research units of the PDX… More
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-22-002 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel… More
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) PAR-22-147 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites U01 cooperative agreement applications for Physical Sciences-Oncology Network (PS-ON). The goal of the… More
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) RFA-CA-21-048 NCI The National Cancer Institutes (NCI) Cancer Systems Biology Consortium (CSBC, supports the application of systems biology approaches to cancer research and includes U01… More
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) PAR-22-105 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration,… More
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed) NOT-CA-22-076 NCI N/A The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) soliciting applications for a Coordinating Center for the Cancer… More
Vote below about this page’s helpfulness.

Enter the characters shown in the image.